Loading data for SLGL — first visit, this takes a few seconds.
Sol-Gel Technologies Ltd. (SLGL)
NasdaqCM: SLGL
· 实时价格 · USD
69.52
-0.58 (-0.83%)
收盘价： Sep 04, 2026, 8:00 PM
69.54
+0.03%
盘后: 6:09 PM
股价、关键数字和最新消息，都在这一页。
Sol-Gel Technologies Ltd.（SLGL）股价、分析与数据
暂无数据
| 买价 | 70 |
| 市值 | 228M |
| 营收（TTM） | 1.79M |
| 净利润（TTM） | -16.3M |
| 1.13 | |
| -5.61 | |
| n/a | |
| -9.03 | |
| 市净率（TTM） | 4.73 |
| 市销率（TTM） | 126.80 |
| 财报日期 | May 1, 2026 |
| 卖价 | 70.8 |
| 成交量 | 29,626 |
| 20日均量 | 51,033 |
| 开盘价 | 69.69 |
| 前收盘价 | 70.10 |
| 日内区间 | 68.39 - 70.80 |
| 52周区间 | 23.13 - 97.97 |
| 分析师 | n/a |
| 目标价 | n/a |
| 分红 | n/a |
| 除息日 | n/a |
关于 SLGL
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It als...
公司完整简介财报意外
Sol-Gel 已于 Aug 20, 2026 发布季度财报：
- 营收为 $591K 低于预期 $0, ， -96.58% 同比下滑.
- 每股收益为 -1.13 超出预期 1.18, ， -127.10% 同比下滑.
第 1 页，共 2 页